Iqvia Holdings Stock Today
IQV Stock | USD 184.90 0.29 0.16% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
IQVIA Holdings is selling for under 184.90 as of the 18th of March 2025; that is 0.16 percent decrease since the beginning of the trading day. The stock's lowest day price was 183.59. IQVIA Holdings has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Note, on February 27, 2025, Senator Markwayne Mullin of US Senate acquired $15k to $50k worth of IQVIA Holdings's common stock.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 9th of May 2013 | Category Healthcare | Classification Health Care |
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina. The company has 176.32 M outstanding shares of which 3.51 M shares are currently shorted by investors with about 2.3 days to cover. More on IQVIA Holdings
Moving together with IQVIA Stock
0.86 | A | Agilent Technologies | PairCorr |
0.74 | ME | 23Andme Holding | PairCorr |
0.63 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
Moving against IQVIA Stock
IQVIA Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
Chairman | Ari Bousbib | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, Health Care, Life Sciences Tools & Services, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Excise Tax Activities | Animal Testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsIQVIA Holdings can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand IQVIA Holdings' financial leverage. It provides some insight into what part of IQVIA Holdings' total assets is financed by creditors.
|
IQVIA Holdings (IQV) is traded on New York Stock Exchange in USA. It is located in 2400 Ellis Road, Durham, NC, United States, 27703 and employs 88,000 people. IQVIA Holdings is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 32.65 B. IQVIA Holdings runs under Life Sciences Tools & Services sector within Health Care industry. The entity has 176.32 M outstanding shares of which 3.51 M shares are currently shorted by investors with about 2.3 days to cover.
IQVIA Holdings has about 1.22 B in cash with 2.72 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.32.
Check IQVIA Holdings Probability Of Bankruptcy
Ownership AllocationIQVIA Holdings has a total of 176.32 Million outstanding shares. The majority of IQVIA Holdings outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IQVIA Holdings to benefit from reduced commissions. Accordingly, third-party entities are subject to a different set of regulations than regular investors in IQVIA Holdings. Please pay attention to any change in the institutional holdings of IQVIA Holdings as this could imply that something significant has changed or is about to change at the company. Please note that on February 27, 2025, Senator Markwayne Mullin of US Senate acquired $15k to $50k worth of IQVIA Holdings's common stock.
Check IQVIA Ownership Details
IQVIA Stock Institutional Holders
Instituion | Recorded On | Shares | |
Amundi | 2024-12-31 | 878.2 K |
IQVIA Holdings Historical Income Statement
IQVIA Stock Against Markets
IQVIA Holdings Corporate Directors
John Danhakl | Independent Director | Profile | |
Carol Burt | Independent Director | Profile | |
John Leonard | Lead Independent Director | Profile | |
James Fasano | Independent Director | Profile |
Additional Tools for IQVIA Stock Analysis
When running IQVIA Holdings' price analysis, check to measure IQVIA Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IQVIA Holdings is operating at the current time. Most of IQVIA Holdings' value examination focuses on studying past and present price action to predict the probability of IQVIA Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IQVIA Holdings' price. Additionally, you may evaluate how the addition of IQVIA Holdings to your portfolios can decrease your overall portfolio volatility.